106 results
Page 2 of 6
8-K
EX-99.1
4q3yqosuzzif8mz6ixw9
14 Apr 23
Other Events
12:38pm
8-K
EX-99.2
be1zpzwzeyo37 alc
14 Apr 23
Other Events
12:38pm
8-K
EX-99.1
qk1ixaom3am833cm
16 Dec 22
Ocugen Announces OCU400 Receives Orphan Drug Designations for Retinitis Pigmentosa and Leber Congenital Amaurosis
6:41am
8-K
EX-99.2
a1cleu
16 Dec 22
Ocugen Announces OCU400 Receives Orphan Drug Designations for Retinitis Pigmentosa and Leber Congenital Amaurosis
6:41am
8-K
EX-99.1
6hm osun2q8
8 Nov 22
Other Events
9:12am
8-K
EX-99.1
jmlodlz8
8 Nov 22
Ocugen Provides Business Update & Third Quarter 2022 Financial Results
7:37am
8-K
EX-99.2
2b0bxn2
8 Nov 22
Ocugen Provides Business Update & Third Quarter 2022 Financial Results
7:37am
8-K
EX-99.1
twzgy
1 Nov 22
Regulation FD Disclosure
8:15am
8-K
EX-99.2
13sqqit7
1 Nov 22
Regulation FD Disclosure
8:15am
8-K
EX-99.1
qbd8i7 9j
14 Sep 22
Ocugen Announces Publication of a Comprehensive Review of BBV152 In Frontiers In Immunology
4:05pm
8-K
EX-99.1
a4g7sx9xsjqbthuw0j
26 Aug 22
Other Events
5:04pm
8-K
EX-99.1
n30ljepno5co6ph9z ex
17 Aug 22
Other Events
4:03pm
8-K
EX-99.1
uy5 s6m8z87s
16 Aug 22
Other Events
4:09pm
8-K
EX-99.1
4lgz3ali2q
5 Aug 22
Ocugen Provides Business Update & Second Quarter 2022 Financial Results
7:35am
424B5
17xsi7kf
10 Jun 22
Prospectus supplement for primary offering
4:56pm
8-K
EX-99.1
47ganfbc bt
24 May 22
Ocugen Announces New Cell Therapy Program Following FDA Regenerative Medicine Advanced Therapy (RMAT) Recognition
7:36am
8-K
EX-99.1
519s2
23 May 22
Other Events
9:02am
8-K
EX-99.3
9fmjbn e9ftd
6 May 22
Ocugen Provides Business Update and First Quarter 2022 Financial Results
6:44am
8-K
EX-99.1
4vrs iinxdctq1jtljex
6 May 22
Ocugen Provides Business Update and First Quarter 2022 Financial Results
6:44am